Key Record Dates
ClinicalTrials.gov Identifier: | NCT05328908 |
---|---|
Brief Title: | A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer (RELATIVITY-123) |
First Submitted : | March 14, 2022 |
First Submitted that Met QC Criteria : | April 13, 2022 |
First Posted : | April 14, 2022 |
Last Update Submitted that Met QC Criteria : | May 15, 2023 |
Last Update Posted : | May 16, 2023 |